Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum

European Journal of Pharmacology

Volumn 542, Issue 1-3, 2006, Pages 92-99

  Kawasaki, Toshiyuki ^a   Ishihara, Kotaro ^a   Ago, Yukio ^a   Nakamura, Shigeo ^a   Itoh, Soichi ^a   Baba, Akemichi ^a   Matsuda, Toshio ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Astrocyte; Dopamine; Edaravone; Methamphetamine; Microglia

Indexed keywords

3 NITROTYROSINE; DOPAMINE; MARKER; METHAMPHETAMINE; NORPHENAZONE; PEROXYNITRITE; SCAVENGER; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; HYPERTHERMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIPYRINE; ASTROCYTES; BODY TEMPERATURE; CELL COUNT; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; FREE RADICAL SCAVENGERS; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; METHAMPHETAMINE; MICE; MICROGLIA; NEURONS; NOREPINEPHRINE; PEROXYNITROUS ACID; RECTUM; SEROTONIN;

EID: 33745986027     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.05.012     Document Type: Article

References (45)

1. 1A receptor-mediated dopamine release in vivo in the frontal cortex of mice. J. Neurochem. 83 (2002) 353-359
2. 1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 45 (2003) 1050-1056
3. Ago Y., Nakamura S., Baba A., and Matsuda T. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex. Neuropsychopharmacology 30 (2005) 43-51
4. Ali S.F., Newport G.D., Holson R.R., Slikker Jr. W., and Bowyer J.F. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658 (1994) 33-38
5. Asanuma M., Tsuji T., Miyazaki I., Miyoshi K., and Ogawa N. Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug. Neurosci. Lett. 352 (2003) 13-16
6. Banno M., Mizuno T., Kato H., Zhang G., Kawanokuchi J., Wang J., Kuno R., Jin S., Takeuchi H., and Suzumura A. The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia. Neuropharmacology 48 (2005) 283-290
7. Cadet J.L., Jayanthi S., and Deng X. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 17 (2003) 1775-1788
8. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Rev. 36 (2001) 1-22
9. De Vito M.J., and Wagner G.C. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28 (1989) 1145-1150
10. Diguet E., Fernagut P.O., Du Wei X.Y., Rouland R., Gross C., Bezard E., and Tison F. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur. J. Neurosci. 19 (2004) 3266-3277
11. Du Y., Ma Z., Lin S., Dodel R.C., Gao F., Bales K.R., Triarhou L.C., Chernet E., Perry K.W., Nelson D.L., Luecke S., Phebus L.A., Bymaster F.P., and Paul S.M. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 669-674
12. Fornai F., Bassi L., Torracca M., Scalori V., and Corsini G.U. Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine in mice. Eur. J. Pharmacol. 283 (1995) 99-102
13. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, Inc., San Diego
14. He Y., Appel S., and Le W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 909 (2001) 187-193
15. Hess A., Desiderio C., and McAuliffe W.G. Acute neuropathological changes in the caudate nucleus caused by MPTP and methamphetamine: immunohistochemical studies. J. Neurocytol. 19 (1990) 338-342
16. Houkin K., Nakayama N., Kamda K., Noujou T., Abe H., and Kashiwaba T. Neuroprotective effects of the free radical scavenger MCI-186 in patients with cerebral infarction: clinical evaluation using magnetic resonance imaging and spectroscopy. J. Stroke Cerebrovasc. Dis. 7 (1998) 315-322
17. Imam S.Z., and Ali S.F. Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation. Brain Res. 855 (2000) 186-191
18. Imam S.Z., Crow J.P., Newport G.D., Islam F., Slikker Jr. W., and Ali S.F. Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst. Brain Res. 837 (1999) 15-21
19. Imam S.Z., Islam F., Itzhak Y., Slikker Jr. W., and Ali S. Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implication for the prevention of methamphetamine-induced neurotoxic damage. Ann. N.Y. Acad. Sci. 914 (2000) 157-171
20. Imam S.Z., Newport G.D., Itzhak Y., Cadet J.L., Islam F., Slikker Jr. W., and Ali S.F. Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J. Neurochem. 76 (2001) 745-749
21. Ischiropoulos H., Zhu L., and Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298 (1992) 446-451
22. Itzhak Y., and Ali S.F. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J. Neurochem. 67 (1996) 1770-1773
23. Itzhak Y., Gandia C., Huang P.L., and Ali S.F. Resistance to neuronal nitric oxide synthase deficient mice to methamphetamine-induced dopaminergic neurotoxicity in vivo. J. Pharmacol. Exp. Ther. 284 (1998) 1040-1047
24. Itzhak Y., Martin J.L., and Ali S.F. Methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice. Synapse 34 (1999) 305-312
25. Kita T., Paku S., Takahashi M., Kubo K., Wagner G.C., and Nakashima T. Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice. Neuropharmacology 37 (1998) 1177-1184
26. Kita T., Wagner G.C., and Nakashima T. Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J. Pharmacol. Sci. 92 (2003) 178-195
27. Koike K., Hashimoto K., Fukami G., Okamura N., Zhang L., Ohgake S., Koizumi H., Matsuzawa D., Kawamura N., Shimizu E., and Iyo M. The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum. Neuropharmacology 48 (2005) 391-397
28. Komine-Kobayashi M., Chou N., Mochizuki H., Nakao A., Mizuno Y., and Urabe T. Dual role of Fcγ receptor in transient focal cerebral ischemia in mice. Stroke 35 (2004) 958-963
29. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
30. Lau J.W., Senok S., and Stadlin A. Methamphetamine-induced oxidative stress in cultured mouse astrocytes. Ann. N.Y. Acad. Sci. 914 (2000) 146-156
31. LaVoie M.J., Card J.P., and Hastings T.G. Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp. Neurol. 187 (2004) 47-57
32. Lu L., Hope B.T., Dempsey J., Liu S.Y., Bossert J.M., and Shaham Y. Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat. Neurosci. 8 (2005) 212-219
33. Miller D.B., and O'Callaghan J.P. Environmental-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamine in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270 (1994) 752-760
34. Mitsumori K., Sakuragi M., Kitami K., Koyanagi I., and Murata J. The effect of MCI-186 on regional cerebral blood flow in patients with acute cerebral infarction. Ther. Res. 19 (1998) 553-565
35. Nakajima A., Yamada K., Nagai T., Uchiyama T., Miyamoto Y., Takayoshi M., He J., Nitta A., Mizuno M., Tran M.H., Seto A., Yoshimura M., Kitaichi K., Hasegawa T., Saito K., Yamada Y., Seishima M., Sekikawa K., Kim H.-C., and Nabeshima T. Role of tumor necrosis factor-α in methamphetamine-induced drug dependence and neurotoxicity. J. Neurosci. 24 (2004) 2212-2225
36. Nicotera P., Bonfoco E., and Brune B. Mechanisms for nitric oxide-induced cell death: involvement of apoptosis. Adv. Neuroimmunol. 5 (1995) 411-420
37. O'Callaghan J.P., and Miller D.B. Neurotoxicity profiles of substituted amphetamine in the C57BL/6 mouse. J. Pharmacol. Exp. Ther. 270 (1994) 741-751
38. Qi X., Okuma Y., Hosoi T., and Nomura Y. Edaravone protects against hypoxia/ischemia-induced endoplasmic reticulum dysfunction. J. Pharmacol. Exp. Ther. 311 (2004) 388-393
39. Schmued L.C., and Bowyer J.F. Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res. 759 (1997) 135-140
40. Thomas D.M., Walker P.D., Benjamins J.A., Geddes T.J., and Kuhn D.M. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J. Pharmacol. Exp. Ther. 311 (2005) 1-7
41. Wagner G.C., Ricaurte G.A., Seiden L.S., Schuster C.R., Miller R.J., and Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181 (1980) 151-160
42. Watanabe T., Yuki S., Egawa M., and Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther. 268 (1994) 1597-1604
43. Yang L., Sugama S., and Chirichigno J.W. Minocycline enhances MPTP toxicity to dopaminergic neurons. J. Neurosci. Res. 74 (2003) 278-285
44. Yoneda Y., Uehara T., Yamasaki H., Kita Y., Tabuch M., and Mori E. Hospital-based study of the care and cost of acute ischemic stroke in Japan. Stroke 34 (2003) 718-724
45. Yu L., and Liao P.-C. Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice. J. Neural Transm. 107 (2000) 419-427